Skip to main content

Factors Modifying the Effect of Prostaglandin E1 on Lipolysis in Adipose Tissue

  • Chapter
Drugs Affecting Lipid Metabolism

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 4))

Abstract

The antilipolytic property of prostaglandins E (PGE) is well known (1). The mechanism behind this effect and its physiological role are not yet clear. Prostaglandins have been extracted from adipose tissue as well as from other tissues (2,3). Catecholamines and nerve stimulation have been shown to provoke secretion of prostaglandins, e.g., from rat epididymal fat pad in vitro (4). Most of the observations about the activity of prostaglandins in adipose tissue in vitro have been made on rats (1,2) and only a few in human tissue (5), with similar results. Systematic studies on the effect of PGE1, on lipolysis with regard to factors such as species, age, nutritional state and hormonal balance are lacking. A condition known to abolish the antilipolytic effect of PGE1 in rat is the fasting state (6,7). The purpose of this study was to explore species differences of PGE1 effects with reference to factors modifying lipolysis.

Supported by the Fonds National Suisse de la Recherche.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Steinberg, D., Vaughan, M., Nestel, P. and Bergström, S. Biochem. Pharmacol. 12: 764 (1963)

    Article  PubMed  CAS  Google Scholar 

  2. Bergström, S., Carlson, L.A. and Weeks, J.R. Pharmacol. Rev. 20: 1 (1968)

    PubMed  Google Scholar 

  3. Karim, S.M.M., Sandler, M. and Williams, E.D. Brit J. Pharmacol. Chemother. 31: 340 (1967)

    CAS  Google Scholar 

  4. Shaw, J. and Ramwell, P.W. J. Biol. Chem. in press

    Google Scholar 

  5. Bergström, S. and Carlson, L.A, Acta Physiol. Scand. 63: 195 (1965)

    Article  Google Scholar 

  6. Carlson, L.A. Progr. Biochem. Pharmacol. 3: 94 (1967)

    CAS  Google Scholar 

  7. Stock, K. and Westermann, E. Arch. Pharm. Exp. Path. 254: 334 (1966)

    CAS  Google Scholar 

  8. Bizzi, A. and Carlson, L.A. Life Sci. 4: 2123 (1965)

    Article  PubMed  CAS  Google Scholar 

  9. Wieland, O. Biochem. Z. 329: 313 (1957)

    PubMed  CAS  Google Scholar 

  10. Butcher, R.W. and Baird, C.E. J. Biol. Chem. 243: 1713 (1968)

    CAS  Google Scholar 

  11. Steinberg, D. and Vaughan, M. in Prostaglandins, Proc. II Nobel Symp. (S. Bergström and B. Samuelsson, Eds.) p. 109. Almqvist & Wiksell, Stockholm (1967)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1969 Plenum Press

About this chapter

Cite this chapter

Micheli, H. (1969). Factors Modifying the Effect of Prostaglandin E1 on Lipolysis in Adipose Tissue. In: Holmes, W.L., Carlson, L.A., Paoletti, R. (eds) Drugs Affecting Lipid Metabolism. Advances in Experimental Medicine and Biology, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6866-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-6866-7_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-6868-1

  • Online ISBN: 978-1-4615-6866-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics